Optimi Health Corp. (CSE:OPTI)
2.300
-0.300 (-11.54%)
Nov 20, 2026, 3:58 PM EST
Optimi Health Revenue
Optimi Health had revenue of 140.20K CAD in the quarter ending June 30, 2026, a decrease of -28.61%. This brings the company's total for the last twelve months to 175.67K, down -67.95% year-over-year. In the fiscal year ending September 30, 2025, Optimi Health had annual revenue of 426.30K with 9.35% growth. That makes Optimi Health the 45,939th largest company in the world by revenue and 1,045th in Canada.
Revenue (ttm)
175.67K
Revenue Growth
-67.95%
P/S Ratio
74.97
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.17M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 426.30K | 36.45K | 9.35% |
| Sep 30, 2024 | 389.85K | 208.76K | 115.28% |
| Sep 30, 2023 | 181.09K | 100.37K | 124.35% |
| Sep 30, 2022 | 80.72K | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ayr Wellness | 650.97M |
| 1CM Inc. | 75.45M |
| Rubicon Organics | 66.86M |
| Red White & Bloom Brands | 52.92M |
| MediPharm Labs | 41.81M |
| Avant Brands | 31.54M |
| Avicanna | 24.65M |
| Greenway Greenhouse Cannabis | 8.06M |
Optimi Health News
- 2 days ago - Optimi Health Sets 2027 Clinical Agenda; Expects First Ibogaine Capsules Soon - Nasdaq
- 2 days ago - Optimi Health Outlines 2027 Plans for OPTI-101 Phase 2b in Major Depressive Disorder and OPTI-201 Phase 3 in PTSD; Announces Shares-for-Debt Settlement - GlobeNewsWire
- 25 days ago - Optimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development Entity - Financial Post
- 25 days ago - Optimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development Entity - GlobeNewsWire
- 4 weeks ago - Optimi Health Completes MDMA Production For Phase 3 PTSD Trial And International Supply - Nasdaq
- 4 weeks ago - Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia - Financial Post
- 4 weeks ago - Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia - GlobeNewsWire
- 5 weeks ago - Optimi Health Transcript: The ThinkEquity Conference - Transcripts